Teva Pharmaceuticals USA has initiated a voluntary nationwide recall of a single lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090), to the consumer level in the United States. This voluntary recall was initiated due to dissolution test failure detected during routine stability testing. No

Fri, 20 May 2022 09:22:12 -0400
Pembrolizumab en combinaison avec une chimioth érapie dans le traitement du cancer du sein triple n égatif (CSTN) m étastatique ou à  r écidive locale inop érable chez l 'adulte n 'ayant jamais re çu de chimioth érapie en contexte de maladie m étastatique dont la tumeur exprime PD-L1 (score combin é positif [SCP] É¥ 10) selon un test valid é.

This update provides additional information on the recall and recommendations for people who use repaired and replaced devices.

CorneaGen is voluntarily recalling the entire lot of Scleral Patch Grafts obtained from (Lot Number) W419221008338